SG10201900876VA - Infectious plasmodium sporozoites grown in vitro - Google Patents
Infectious plasmodium sporozoites grown in vitroInfo
- Publication number
- SG10201900876VA SG10201900876VA SG10201900876VA SG10201900876VA SG10201900876VA SG 10201900876V A SG10201900876V A SG 10201900876VA SG 10201900876V A SG10201900876V A SG 10201900876VA SG 10201900876V A SG10201900876V A SG 10201900876VA SG 10201900876V A SG10201900876V A SG 10201900876VA
- Authority
- SG
- Singapore
- Prior art keywords
- vitro
- plasmodium sporozoites
- grown
- stage
- infectious plasmodium
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
- C12N1/10—Protozoa; Culture media therefor
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/002—Protozoa antigens
- A61K39/015—Hemosporidia antigens, e.g. Plasmodium antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P33/00—Antiparasitic agents
- A61P33/10—Anthelmintics
- A61P33/12—Schistosomicides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
- A61K2039/52—Bacterial cells; Fungal cells; Protozoal cells
- A61K2039/522—Bacterial cells; Fungal cells; Protozoal cells avirulent or attenuated
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
- Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
- Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
- Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Tropical Medicine & Parasitology (AREA)
- Engineering & Computer Science (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Microbiology (AREA)
- Organic Chemistry (AREA)
- Veterinary Medicine (AREA)
- Wood Science & Technology (AREA)
- Biotechnology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Biomedical Technology (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- General Engineering & Computer Science (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Farming Of Fish And Shellfish (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201461987834P | 2014-05-02 | 2014-05-02 | |
| US201462016981P | 2014-06-25 | 2014-06-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG10201900876VA true SG10201900876VA (en) | 2019-03-28 |
Family
ID=54359397
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201608935TA SG11201608935TA (en) | 2014-05-02 | 2015-05-01 | Infectious plasmodium sporozoites grown in vitro |
| SG10201900876VA SG10201900876VA (en) | 2014-05-02 | 2015-05-01 | Infectious plasmodium sporozoites grown in vitro |
Family Applications Before (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201608935TA SG11201608935TA (en) | 2014-05-02 | 2015-05-01 | Infectious plasmodium sporozoites grown in vitro |
Country Status (12)
| Country | Link |
|---|---|
| US (5) | US9878026B2 (fr) |
| EP (1) | EP3137106B1 (fr) |
| JP (2) | JP7021851B2 (fr) |
| KR (1) | KR102467128B1 (fr) |
| CN (1) | CN106413746A (fr) |
| AP (1) | AP2016009590A0 (fr) |
| AU (1) | AU2015252843B2 (fr) |
| CA (1) | CA2947595A1 (fr) |
| ES (1) | ES2954144T3 (fr) |
| IL (1) | IL248500B (fr) |
| SG (2) | SG11201608935TA (fr) |
| WO (1) | WO2015168620A1 (fr) |
Families Citing this family (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR102467128B1 (ko) | 2014-05-02 | 2022-11-15 | 사나리아 인코퍼레이티드 | 생체 외 성장된 감염성 플라스모디움 종충 |
| EP3265815A4 (fr) | 2015-03-04 | 2018-08-15 | Sanaria Inc. | Dosage d'anticorps sériques permettant de déterminer la protection contre le paludisme et vaccins sous-unitaires dirigés contre les stades pré-érythrocytaires |
| US11332711B1 (en) | 2018-04-05 | 2022-05-17 | University Of South Florida | Sporozoite cryopreservation compositions and methods |
Family Cites Families (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4824671A (en) * | 1986-03-24 | 1989-04-25 | Reuter Laboratories, Inc. | In vitro method for producing infective bacterial spores and spore-containing insecticidal compositions |
| US7015036B2 (en) | 2000-09-25 | 2006-03-21 | The United States Of America As Represented By The Secretary Of The Army | Human liver cell line |
| US8802919B2 (en) | 2002-04-05 | 2014-08-12 | Sanaria Inc. | Apparatuses and methods for the production of haematophagous organisms and parasites suitable for vaccine production |
| WO2003087322A2 (fr) * | 2002-04-05 | 2003-10-23 | Sanaria Inc. | Appareils et procedes de production d'organismes hematophages et parasites destines a la production de vaccins |
| US20050208078A1 (en) | 2003-11-20 | 2005-09-22 | Hoffman Stephen L | Methods for the prevention of malaria |
| ATE524735T1 (de) * | 2002-11-20 | 2011-09-15 | Sanaria Inc | Impfstoff zur vorbeugung gegen malaria |
| US20050220822A1 (en) * | 2003-11-20 | 2005-10-06 | Hoffman Stephen L | Methods for the prevention of malaria |
| EP2128613A1 (fr) * | 2008-05-28 | 2009-12-02 | Institut Pasteur | Procédé pour l'analyse de composés et leur habilité à augmenter la rigidité de globules rouges infectés par un parasite protozoaire du genre Plasmodium et application correspondante |
| DK2387416T3 (en) | 2009-01-16 | 2017-09-25 | Sanaria Inc | PURIFIED PLASMODIUM AND VACCINE COMPOSITIONS |
| US20120288525A1 (en) | 2011-05-11 | 2012-11-15 | Chakravarty Sumana | Pharmaceutical compositions comprising attenuated plasmodium sporozoites and glycolipid adjuvants |
| EP2956166B1 (fr) | 2013-01-25 | 2019-01-16 | Sanaria Inc. | Atténuation génétique de plasmodium par rupture du gène b9 |
| US20160216276A1 (en) | 2013-08-30 | 2016-07-28 | Sanaria Inc. | Serum antibody assay for determining protection from malaria, and pre-erythrocytic subunit vaccines |
| KR102467128B1 (ko) | 2014-05-02 | 2022-11-15 | 사나리아 인코퍼레이티드 | 생체 외 성장된 감염성 플라스모디움 종충 |
| EP3265815A4 (fr) | 2015-03-04 | 2018-08-15 | Sanaria Inc. | Dosage d'anticorps sériques permettant de déterminer la protection contre le paludisme et vaccins sous-unitaires dirigés contre les stades pré-érythrocytaires |
-
2015
- 2015-05-01 KR KR1020167033486A patent/KR102467128B1/ko active IP Right Grant
- 2015-05-01 EP EP15786133.7A patent/EP3137106B1/fr active Active
- 2015-05-01 SG SG11201608935TA patent/SG11201608935TA/en unknown
- 2015-05-01 ES ES15786133T patent/ES2954144T3/es active Active
- 2015-05-01 CA CA2947595A patent/CA2947595A1/fr active Pending
- 2015-05-01 AP AP2016009590A patent/AP2016009590A0/en unknown
- 2015-05-01 AU AU2015252843A patent/AU2015252843B2/en active Active
- 2015-05-01 JP JP2016565490A patent/JP7021851B2/ja active Active
- 2015-05-01 IL IL248500A patent/IL248500B/en unknown
- 2015-05-01 CN CN201580027926.2A patent/CN106413746A/zh active Pending
- 2015-05-01 SG SG10201900876VA patent/SG10201900876VA/en unknown
- 2015-05-01 WO PCT/US2015/028890 patent/WO2015168620A1/fr active Application Filing
-
2016
- 2016-04-11 US US15/095,360 patent/US9878026B2/en active Active
-
2017
- 2017-12-29 US US15/858,574 patent/US10441646B2/en active Active
-
2019
- 2019-09-05 US US16/561,814 patent/US11207395B2/en active Active
-
2020
- 2020-05-18 JP JP2020086757A patent/JP2020141691A/ja active Pending
-
2021
- 2021-11-18 US US17/529,812 patent/US11883475B2/en active Active
-
2023
- 2023-12-07 US US18/532,731 patent/US20240173393A1/en active Pending
Also Published As
| Publication number | Publication date |
|---|---|
| IL248500A0 (en) | 2016-12-29 |
| EP3137106B1 (fr) | 2023-07-05 |
| US20220257742A1 (en) | 2022-08-18 |
| US10441646B2 (en) | 2019-10-15 |
| WO2015168620A1 (fr) | 2015-11-05 |
| BR112016025199A2 (pt) | 2017-08-15 |
| KR102467128B1 (ko) | 2022-11-15 |
| BR112016025199A8 (pt) | 2021-07-13 |
| AU2015252843A1 (en) | 2016-11-17 |
| US11207395B2 (en) | 2021-12-28 |
| US20180161413A1 (en) | 2018-06-14 |
| ES2954144T3 (es) | 2023-11-20 |
| US11883475B2 (en) | 2024-01-30 |
| US20240173393A1 (en) | 2024-05-30 |
| JP2017514490A (ja) | 2017-06-08 |
| US9878026B2 (en) | 2018-01-30 |
| SG11201608935TA (en) | 2016-11-29 |
| AU2015252843B2 (en) | 2020-12-24 |
| JP7021851B2 (ja) | 2022-02-17 |
| KR20160147985A (ko) | 2016-12-23 |
| CA2947595A1 (fr) | 2015-11-05 |
| CN106413746A (zh) | 2017-02-15 |
| EP3137106A4 (fr) | 2018-01-17 |
| AP2016009590A0 (en) | 2016-11-30 |
| JP2020141691A (ja) | 2020-09-10 |
| EP3137106A1 (fr) | 2017-03-08 |
| US20160287688A1 (en) | 2016-10-06 |
| IL248500B (en) | 2022-07-01 |
| US20200113987A1 (en) | 2020-04-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP3433222A4 (fr) | Acide acrylique et procédés de production de ceux-ci | |
| EP3684434A4 (fr) | Construction tissulaire, procédés de production et d'utilisation de celle-ci | |
| EP3361987A4 (fr) | Greffons de tissu mou, et leurs procédés de fabrication et d'utilisation | |
| EP3426722A4 (fr) | Procédé de production de produits cellulosiques à mémoire de forme et produits cellulosiques à mémoire de forme ainsi obtenus | |
| EP3435860A4 (fr) | Procédés et dispositifs d'imagerie magnétique pour inventaire de fonction corticale cérébrale humaine | |
| CA164874S (en) | Chair | |
| EP3461845A8 (fr) | Anticorps et immunoconjugués anti-cd33 | |
| EP4252681A3 (fr) | Objets implantables, dispositifs de guidage, et procédés d'utilisation | |
| EP2968577A4 (fr) | Microsphères de buprénorphine à forte charge de médicament et leur procédé de fabrication | |
| EP3946034A4 (fr) | Procédés et dispositifs d'imagerie magnétique pour examiner la fonction corticale du cerveau humain | |
| SG11202100319XA (en) | Non-immunogenic engineered tissue and methods of producing and using the same | |
| CA143419S (en) | Electronic article surveillance pedestal antenna | |
| MX2020005027A (es) | Compuestos y metodos sinteticos para la preparacion de retinodes especificos del receptor x retinoide. | |
| EP3037919A4 (fr) | Interface de biosignal vestimentaire et méthode de fonctionnement d'interface de biosignal vestimentaire | |
| EP3334826A4 (fr) | Pavot à teneur élevée en thébaïne et procédés de production associés | |
| SG10201900876VA (en) | Infectious plasmodium sporozoites grown in vitro | |
| GB201706328D0 (en) | Methods of producing SAPO-56, and AFX-containing molecular sieve | |
| EP3691523A4 (fr) | Procédés et dispositifs d'imagerie magnétique pour l'inventaire d'une fonction corticale cérébrale humaine | |
| EP3002854A3 (fr) | Aimant lié et son procédé de fabrication | |
| EP3437550A4 (fr) | Procédé de surveillance de la santé et vêtement de surveillance de la santé | |
| HK1246215A1 (zh) | 去細胞角膜及其製備方法和用途 | |
| EP2984167A4 (fr) | Souches mutantes du virus de la vaccine, utilisation de celles-ci, et procédé de production de celles-ci | |
| HUE064463T2 (hu) | Hosszantartó hatású VII. koagulációs faktor és az elõállítására vonatkozó eljárások | |
| EP3302473A4 (fr) | Préparation de citrate de sufentanile et base de sufentanile | |
| MX2018014253A (es) | Inmunógenos de malaria sintéticos, combinaciones de estos y su uso para prevenir y tratar infecciones de malaria. |